Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
01.07. | University of Liverpool launches new biotech spin-out company Galytx | ||
01.07. | ICL granted £150,000 to explore link between breast cancer and breastfeeding | ||
28.06. | UK study reveals persistent challenges in heart health and cardiovascular diseases | ||
28.06. | Parkinson's UK awards ICL £100,000 to develop small drugs for Parkinson's disease | ||
27.06. | New collaboration aims to research early mutations in rare blood disorder | ||
27.06. | UCL begins first UK deep brain stimulation study for children with rare epilepsy | ||
26.06. | Innovative Health Initiative's new funding round to include topics on CVD and arthritis | ||
26.06. | Researchers reveal how a protein interaction can increase Alzheimer's risk | ||
25.06. | Scientists uncover new disease-driving mechanism to treat atheroschlerosis | ||
25.06. | Study shows cholesterol-lowering drug reduces diabetic retinopathy risk | ||
24.06. | UK dementia organisations publish new manifesto ahead of general election | ||
24.06. | Europe contributes over €750m to African Vaccines Manufacturing Accelerator | ||
21.06. | KCL's mini liver model promises more effective drug testing method | ||
21.06. | New 'space hairdryer' to regenerate heart tissue after bypass surgery | ||
20.06. | US study suggests BMS' cancer drug could target Parkinson's-causing protein | ||
20.06. | Lab-grown 'mini guts' to help identify treatment for Crohn's disease | ||
19.06. | Researchers design genetic mole reversal therapy for rare skin condition | ||
19.06. | Researchers reveal genetic makeup could identify treatment options for sepsis | ||
18.06. | UMC Utrecht and VectorY collaborate to identify biomarkers of ALS in new study | ||
18.06. | Researchers identify link between gum disease and young-onset stroke in patients | ||
17.06. | Leuko device to remotely monitor cancer patients during chemotherapy | ||
17.06. | Ten-minute brain scan could improve diagnosis for paediatric brain cancer | ||
14.06. | Francis Crick, UCL and AstraZeneca identify why treatment fails for NSCLC patients | ||
14.06. | Royal Marsden launches first UK genome testing facility to improve testing for cancer | ||
13.06. | Sysmex receives Longitude Prize on AMR for antimicrobial testing system |